BioInvent International

BioInvent International EBIT per Share

The EBIT per Share of BioInvent International (BINV.ST) as of Oct 10, 2026 is -5.34 SEK. In the previous year, EBIT per Share was -7.17 SEK — a change of -25.63% (higher).

EBIT per Share

-5.34SEK

YoY

-25.63%

Last updated:

EBIT per Share of BioInvent International is 2025 -5.34 SEK. EBIT per Share of BioInvent International was 2024 -7.17 SEK. It decreases by -25.63% higher compared to the previous year.

The BioInvent International EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-5.62 SEK
Jan 1, 2024
-7.17 SEK
Jan 1, 2025
-5.34 SEK
Jan 1, 2026 (e)
-2.09 SEK
Jan 1, 2027 (e)
-7.52 SEK
Jan 1, 2028 (e)
-1.03 SEK
Jan 1, 2029 (e)
-0.50 SEK
Jan 1, 2030 (e)
-0.50 SEK
The BioInvent International EBIT per Share history
YEAREBIT per ShareYoY
est-0.50SEK0.00%
est-0.50SEK-51.29%
est-1.03SEK-86.31%
est-7.52SEK+259.75%
est-2.09SEK-60.81%
-5.34SEK-25.63%
-7.17SEK+27.59%
-5.62SEK+617.34%
-0.78SEK-84.74%
-5.14SEK+122.12%
-2.31SEK-63.87%
-6.40SEK-20.98%
-8.10SEK+0.60%
-8.05SEK+49.25%
-5.40SEK-59.54%
-13.33SEK+35.58%
-9.83SEK+107.36%
-4.74SEK-90.48%
-49.84SEK+142.39%
-20.56SEK-48.70%
-40.08SEK-28.78%
-56.28SEK-2,588.77%
2.26SEK-74.24%
8.78SEK-119.34%
-45.38SEK—
Access this data via the Eulerpool API
Get Free API Key

BioInvent International Stock analysis

What does BioInvent International do? BioInvent International AB is a Swedish biopharmaceutical company specializing in the discovery and development of therapeutic antibodies. It was founded in 1986 and is headquartered in Lund, Sweden. BioInvent conducts research and development activities in the fields of immuno-oncology, inflammatory diseases, and fibrosis. BioInvent International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioInvent International stock

EBIT per Share of BioInvent International is -5.34 SEK in 2025.

EBIT per Share of BioInvent International changed from -7.17 SEK to -5.34 SEK, representing a -25.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share BioInvent International since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioInvent International

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioInvent International